New funding from Dr. Song augments $3.0 million in funding advances from AlpineBrook Capital in 2025 above and beyond the $5.5 million proceeds and additional $4 million commitments in previously ...

Since its launch in 2006, the biotechnology company has not only answered questions about family trees, but also about genetic probabilities, such as whether you think cilantro tastes like soap or ...

CreateLED, the global leader in premium MicroLED display technology, announced today its upcoming debut at Art Basel ...

A dozen Canadian groups are leading exhibition at this year's Venice Biennale, which opened this month. Here's what they have ...

Longtime Omaha television reporter John Chapman is honored with his Face on the Barroom Floor at the Omaha Press Club.

Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions ... [email protected] Juvenescence is a clinical-stage AI-enabled biotech company ...

PVR INOX, India's largest and most premium cinema exhibition company, proudly announces the launch of its first Director's Cut in Noida at DLF Mall of India, under its luxury arm-The Luxury Collection ...

Cognyte Software Ltd. ("Cognyte"), a global leader in investigative analytics software, today announced a significant follow-on order, valued at over $5 million, with a longstanding law enforcement ...

In a look ahead at a week of Cambridge and Somerville events, Inman Eats & Crafts is back, there's a Harvard Square Block ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

The company expects to lay off the majority of its workforce by the end of the second fiscal quarter, according to SEC filings. Mural Oncology is a biotechnology company that focuses on using its ...